drugset / Trial / NCT01732809

Fields Of Effects Of Two Commercial Preparations Of Botulinum Toxin Type A At Equal Labeled Unit Doses

NCT01732809

Phase 4 Completed 19 enrolled Hexsel Dermatology Clinic
RandomizedParallel-groupDouble-blindOther

Summary

The purpose of this study is to assess the fields of anhydrotic effect (FAE) of abobotulinumtoxinA and onabotulinumtoxinA at the same labeled unit dose (1:1 units), comparing both sweat gland and muscle activity.

Timeline

Start
2011-01
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 2 iu Other

Indications